Virology Specimen Collection Market Size was valued at USD 5.8 Billion in 2022. The Virology Specimen Collection market Product Type is projected to grow from USD 6.1 Billion in 2023 to USD 9.2 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.30% during the forecast period (2023 - 2032). Government funding growth, widespread swab use, regulatory agency approval of specimen collection kits, and rising demand for at-home kits to lower the risk of virus transmission, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
In April 2021, MediBuddy, a digital healthcare platform that operates without the need for payment, introduced a COVID-19 laboratory exam for individuals residing in Mumbai, Pune, and New Delhi. The test is conducted by authorized pathological laboratories that are listed by the government. The prescription for the test will be obtained through an online doctor consultation, following the ICMR criteria.
One of the main factors driving up the demand for efficient virology specimen collection is the increased prevalence of viral infections like AIDS, the flu, SARS-CoV-2, EBOLA, STDs, and the Zika virus. The World Health Organisation (WHO) estimates that at the end of 2020, there were 37.7 million HIV-positive persons worldwide. Out of these, the WHO African Region was home to over two-thirds (25.4 million) of the population. In 2020, 1.5 million (1.0-2.0 million) individuals contracted the illness, and around 680,000 people perished from HIV-related causes. Additionally, according to information released by the World Health Organisation (WHO) in July 2021, there were reportedly 7 million new cases of syphilis worldwide in 2020. Over 1 million sexually transmitted diseases (STIs) are contracted every day worldwide, according to data released by the World Health Organisation (WHO) in November 2021. This is then expected to further fuel the market for virology specimen collection.
Nasopharyngeal (NP) swabs are expected to increase in popularity as antigen tests become available to close timing and capacity limitations in the testing landscape. The appearance of the infectious Delta version of COVID-19 has also raised the need for tests in recent months. For instance, in August 2020, the US Department of Defence awarded a contract worth USD 51 million to Puritan Medical Products (US) in coordination with the Department of Health and Human Services (HHS). The money is intended to help the company increase its monthly production capacity of flock tip testing swabs to 50 million swabs by March 2021 to facilitate coronavirus testing.
In addition, the rising incidence of viral diseases and the appearance of new pathogens are anticipated to be the main drivers of the market's expansion. The World Health Organisation (WHO) estimates that in 2021, various infectious diseases affected 60% of the world's population. The need for virology specimen collection has increased as a result of the expanding prevalence of viral infections such the human immunodeficiency virus (HIV), influenza, Ebola, Zika virus, and other STDs. The Human Immunodeficiency Virus (HIV) was present in 38.4 million people as of the World Health Organization's (WHO) January 2021 update. Likewise, according to a Food and Agriculture Organisation (FAO) report released in January 2022, China recorded 13 new instances of the avian influenza virus while the United Kingdom reported 5 cases. Due to the effective detection and treatment of viral illnesses, the rising frequency of viral diseases and the advent of new viral infections has increased the demand for virology specimen collections, which will drive the market's growth during the ensuing years. Thus, driving the Virology Specimen Collection market revenue.
The Virology Specimen Collection market segmentation, based on product type, includes swabs, viral transport media, blood collection kits, and others. Swabs segment dominated the market in 2022. Swabs are tiny bits of soft material that are used to clean cuts, collect a tiny amount of substance from the body for testing, or both. The Centres for Disease Control and Prevention (CDC) reported that there are two ways to package sterile swabs for collecting upper respiratory specimens: either individually wrapped or in bulk.
The Virology Specimen Collection market segmentation, based on application, includes diagnostics and research. Diagnosis segment dominated the market in 2022. The virology specimen collection kit allows samples to be taken from the patient's nose using an approved self-collection kit that contains nasal swabs and saline to diagnose the condition based on the patient's symptoms and indicators.
The Virology Specimen Collection market segmentation, based on end user, includes hospitals & clinics, diagnostic centers, and others. Hospitals & clinics segment dominated the Virology Specimen Collection market in 2022.This is due to an increase in patients with respiratory virus infections and the rising need for viral disease treatment and diagnostics. Due to the unexpected surge in COVID-19 infectious cases around the world, there was also an increase in the demand for virology specimen collection.
Figure 1: Virology Specimen Collection Market, by End User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North America Virology Specimen Collection Market dominated this market in 2022 (45.80%). Laboratory Corporation of America (LabCorp) will be the first diagnostic test developer for an at-home specimen collection kit for COVID-19, according to the US Food and Drug Administration (FDA), in April 2020. During the projected period, it is anticipated that this will increase demand for virology specimen collection throughout the region. Further, the U.S. Virology Specimen Collection market held the largest market share, and the Canada Virology Specimen Collection market was the fastest growing market in the North America region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: VIROLOGY SPECIMEN COLLECTION MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Virology Specimen Collection market accounted for the healthy market share in 2022. The World Health Organisation (WHO) and the European Centre for Disease Prevention and Control (ECDC) are cooperating closely to determine the laboratory needs and capacities in the European region, according to the WHO's January 2020 report. As a result of the growth in COVID-19 cases and the occurrence of viral infections, sample collection kits are needed for laboratory tests and detection. This is anticipated to fuel the market's expansion for virology specimen collection.Further, the German Virology Specimen Collection market held the largest market share, and the U.K Virology Specimen Collection market was the fastest growing market in the European region.
The Asia Pacific Virology Specimen Collection market is expected to register significant growth from 2023 to 2032. The Asian Development Bank (ADB) announced in April 2021 a USD 31.6 billion aid package for the Asia and Pacific area in 2020 to address the epidemic and boost green and sustainable green recovery in response to the outbreak of COVID-19 infections. Therefore, the virology specimen collecting market is anticipated to rise as a result of an increase in government financing. Moreover, China’s Virology Specimen Collection market held the largest market share, and the Indian Virology Specimen Collection market was the fastest growing market in the Asia-Pacific region.
Virology Specimen Collection Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Virology Specimen Collection market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Virology Specimen Collection Industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Virology Specimen Collection Industry to benefit clients and increase the market sector. In recent years, the Virology Specimen Collection Industry has offered some of the most significant advantages to medicine. Major players in the Virology Specimen Collection market, including Hardy Diagnostics, Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., BNTX Inc., Formlabs, Medline Industries, Inc., Laboratory Corporation of America Holdings, VIRCELL S.L., Lucence Diagnostics Pte Ltd., and HiMedia Laboratories, are attempting to increase market demand by investing in research and development operations.
The company Covaris, LLC creates sophisticated sample preparation tools for genomic and proteomic research. The business provides technologies for tools, kits, tubes and vials, reagents, and accessories, enabling customers to discover new things, create new assays, and enhance bioanalytical outcomes. The truXTRAC viral RNA extraction kit and the truXTRAC-PCR direct viral RNA extraction kit are two new kits that Covaris, LLC introduced in February 2020 for the extraction of viral RNA from nose or throat swab sample collecting devices.
For tests like COVID-19, Rhinostics creates sample collecting kits to improve the productivity, accuracy, and security of labs. In comparison to traditional sample collecting methods, the company's patient-centric sample collection offers efficiencies to the laboratory that remove costs and save time, allowing labs to cut time and labour costs, increase safety, reduce sample contamination, and lower error rates. With the introduction of the VERIstic collection equipment designed specifically for tiny volume blood collection in the United States in July 2022, Rhinostics made a significant advancement in automated sample collection technology.
Key Companies in the Virology Specimen Collection market include
Hardy Diagnostics
Puritan Medical Products
COPAN Diagnostics
Becton, Dickinson and Company
Thermo Fisher Scientific, Inc.
BNTX Inc.
Formlabs
Medline Industries, Inc.
Laboratory Corporation of America Holdings
VIRCELL S.L.
Lucence Diagnostics Pte Ltd.
HiMedia Laboratories
Virology Specimen Collection Industry Developments
March 2022:The InhibiSURE Viral Inactivation Medium was created by Thermo Fisher Scientific and introduced in Europe. The SARS-CoV-2 virus can be obtained and quickly rendered inactive using this new viral transport medium, which also stabilises viral RNA at room temperature for transportation and usage in in vitro diagnostic testing methods.
Swabs
Viral Transport Media
Blood Collection Kits
Others
Diagnostics
Research
Hospitals & Clinics
Diagnostic Centers
Others
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 5.8 Billion |
| Market Size 2023 | USD 6.1 Billion |
| Market Size 2032 | USD 9.2 Billion |
| Compound Annual Growth Rate (CAGR) | 5.30% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Product Type, Application, End User, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Hardy Diagnostics, Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., BNTX Inc., Formlabs, Medline Industries, Inc., Laboratory Corporation of America Holdings, VIRCELL S.L., Lucence Diagnostics Pte Ltd., and HiMedia Laboratories |
| Key Market Opportunities | Rise in demand for rapid diagnostic tests |
| Key Market Dynamics | Approval of specimen collection kits by regulatory authorities, large volume and usage rate of swabs, increase in government funding, and rise in the demand for at-home kits for reducing the risk of virus transmission |
Virology Specimen Collection Market Highlights:
Frequently Asked Questions (FAQ) :
The Virology Specimen Collection market size was valued at USD 5.8 Billion in 2022.
The market is projected to grow at a CAGR of 5.30% during the forecast period, 2023-2032.
North America had the largest share in the market
The key players in the market are Hardy Diagnostics, Puritan Medical Products, COPAN Diagnostics, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., BNTX Inc., Formlabs, Medline Industries, Inc., Laboratory Corporation of America Holdings, VIRCELL S.L., Lucence Diagnostics Pte Ltd., and HiMedia Laboratories
The Swabs Product Type dominated the market in 2022.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
